ClinicalTrials.gov
ClinicalTrials.gov Menu

Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed (LENDEXAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01194791
Recruitment Status : Completed
First Posted : September 3, 2010
Last Update Posted : April 25, 2017
Sponsor:
Information provided by (Responsible Party):
PETHEMA Foundation